266 related articles for article (PubMed ID: 31286669)
1. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
[TBL] [Abstract][Full Text] [Related]
2. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
[TBL] [Abstract][Full Text] [Related]
3. Genetic inhibition of FABP4 attenuated endoplasmic reticulum stress and mitochondrial dysfunction in rhabdomyolysis-induced acute kidney injury.
Liu J; Huang R; Li X; Guo F; Li L; Zeng X; Ma L; Fu P
Life Sci; 2021 Mar; 268():119023. PubMed ID: 33434534
[TBL] [Abstract][Full Text] [Related]
4. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
[TBL] [Abstract][Full Text] [Related]
5. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
6. FABP4 inhibitor BMS309403 protects against hypoxia-induced H9c2 cardiomyocyte apoptosis through attenuating endoplasmic reticulum stress.
Sun F; Du J; Li H; Hao S; Zhao G; Lu F
J Cell Mol Med; 2020 Oct; 24(19):11188-11197. PubMed ID: 32896039
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury.
Huang R; Shi M; Guo F; Feng Y; Feng Y; Liu J; Li L; Liang Y; Xiang J; Lei S; Ma L; Fu P
Front Pharmacol; 2018; 9():917. PubMed ID: 30135658
[TBL] [Abstract][Full Text] [Related]
8. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
9. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against renal ischemia-reperfusion injury.
Shi M; Huang R; Guo F; Li L; Feng Y; Wei Z; Zhou L; Ma L; Fu P
RSC Adv; 2018 Apr; 8(27):15207-15214. PubMed ID: 35541316
[TBL] [Abstract][Full Text] [Related]
11. Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis.
Feng Y; Huang R; Guo F; Liang Y; Xiang J; Lei S; Shi M; Li L; Liu J; Feng Y; Ma L; Fu P
Front Pharmacol; 2018; 9():274. PubMed ID: 29632491
[TBL] [Abstract][Full Text] [Related]
12. FABP4 inhibitor attenuates inflammation and endoplasmic reticulum stress of islet in leptin receptor knockout rats.
Yao F; Jiang DD; Guo WH; Guo LS; Gao MM; Bai Y; Wang X; Zhang LS
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12808-12820. PubMed ID: 33378030
[TBL] [Abstract][Full Text] [Related]
13. Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis.
Huang Z; Guo F; Xia Z; Liang Y; Lei S; Tan Z; Ma L; Fu P
Biomed Pharmacother; 2020 Jun; 126():110056. PubMed ID: 32145589
[TBL] [Abstract][Full Text] [Related]
14. Valsartan Protects Against Contrast-Induced Acute Kidney Injury in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis.
Sun Y; Peng PA; Ma Y; Liu XL; Yu Y; Jia S; Xu XH; Wu SJ; Zhou YJ
Curr Vasc Pharmacol; 2017; 15(2):174-183. PubMed ID: 27781957
[TBL] [Abstract][Full Text] [Related]
15. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
17. FABP4 silencing ameliorates hypoxia reoxygenation injury through the attenuation of endoplasmic reticulum stress-mediated apoptosis by activating PI3K/Akt pathway.
Deng T; Wang Y; Wang C; Yan H
Life Sci; 2019 May; 224():149-156. PubMed ID: 30904493
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis.
Wang B; Xu J; Ren Q; Cheng L; Guo F; Liang Y; Yang L; Tan Z; Fu P; Ma L
Cell Death Dis; 2022 Apr; 13(4):333. PubMed ID: 35410456
[TBL] [Abstract][Full Text] [Related]
19. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F
Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
[TBL] [Abstract][Full Text] [Related]
20. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
